FLASHNEWS:

Macter International Reports Decline in Earnings Amid Higher Tax Rate

Karachi: Macter International faced a reduction in earnings for the fiscal year 2026, largely attributed to an increased effective tax rate, as revealed in a corporate briefing. The pharmaceutical company's earnings for the year amounted to PkR698 million, marking a 5 percent decline from the previous year's PkR738 million. This decrease was primarily due to a higher effective tax rate of 44.2 percent, stemming from prior-year adjustments, in contrast to the previous fiscal year's rate of 34.9 percent.

According to AKD Securities Limited, Macter International reported a significant 18 percent increase in topline revenue, reaching PkR11.7 billion in FY26, up from PkR9.9 billion in FY25. This growth was driven by the expansion of the local product portfolio, the introduction of new products in low-competition markets, and increased export volumes. Excluding sales to Afghanistan, overall sales rose by 22 percent year-on-year, while export sales experienced a 2.5-fold increase.